纳米载药系统应用于缺血性脑卒中的研究进展(5)
[20] VIEIRA DB，GAMARRA LF. Getting into the brain：liposome-based strategies for effective drug delivery across the blood-brain barrier[J]. Int J Nanomedicine，2016，11：5381-5414.
[21] BOZZUTO G，MOLINARI A. Liposomes as nanomedical devices[J]. Int J Nanomedicine，2015，10：975-999.
[22] PATEL T， ZHOU J， PIEPMEIER JM， et al. Polymeric nanoparticles for drug delivery to the central nervous system[J]. Adv Drug Deliv Rev，2012，64(7)：701-705.
, 百拇医药
[23] DANHIER F，ANSORENA E，SILVA JM，et al. PLGA- based nanoparticles：an overview of biomedical applications[J]. J Control Release，2012，161(2)：505-522.
[24] NAIR SB，DILEEP A，RAJANIKANT GK. Nanotechnology based diagnostic and therapeutic strategies for neuroscience with special emphasis on ischemic stroke[J]. Curr Med Chem，2012，19(5)：744-756.
[25] REDDY MK，WU L，KOU W，et al. Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress[J]. Appl Biochem Biotechnol，2008，151(2/3)：565-577.
, 百拇医药
[26] REDDY MK，LABHASETWAR V. Nanoparticle-mediated delivery of superoxide dismutase to the brain：an effective strategy to reduce ischemia-reperfusion injury[J]. FASEB J，2009，23(5)：1384-1395.
[27] CHEN H，SPAGNOLI F，BURRIS M，et al. Nanoerythropoietin is 10-times more effective than regular erythropoietin in neuroprotection in a neonatal rat model of hypoxia and ischemia[J]. Stroke，2012，43(3)：884-887.
[28] MDZINARISHVILI A，SUTARIYA V，TALASILA PK，et al. Engineering triiodothyronine(T3)nanoparticle for use in ischemic brain stroke[J]. Drug Deliv Transl Res，2013，3(4)：309-317.
, http://www.100md.com
[29] MOHAMMADI-SAMANI S，TAGHIPOUR B. PLGA micro and nanoparticles in delivery of peptides and proteins；problems and approaches[J]. Pharm Dev Technol，2014，20(4)：385-393.
[30] SOARES PIP，SOUSA AI，SILVA JC，et al. Chitosan- based nanoparticles as drug delivery systems for doxorubicin：optimization and modelling[J]. Carbohydr Polym，2016，147：304-312.
[31] RAMPINO A，BORGOGNA M，BLASI P，et al. Chitosan nanoparticles：preparation，size evolution and stability[J].Int J Pharm，2013，455(1/2)：219-228.
, 百拇医药
[32] AHMAD N，AHMAD R，NAQVI AA，et al. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of cerebral ischemia[J]. Int J Biol Macromol，2016，91：640-655.
[33] VERMA SK，ARORA I，JAVED K，et al. Enhancement in the neuroprotective power of riluzole against cerebral ischemia using a brain targeted drug delivery vehicle[J]. ACS Appl Mater Interfaces，2016，8(30)：19716-19723., 百拇医药(吴雅云 庞鑫 刘刚)
[21] BOZZUTO G，MOLINARI A. Liposomes as nanomedical devices[J]. Int J Nanomedicine，2015，10：975-999.
[22] PATEL T， ZHOU J， PIEPMEIER JM， et al. Polymeric nanoparticles for drug delivery to the central nervous system[J]. Adv Drug Deliv Rev，2012，64(7)：701-705.
, 百拇医药
[23] DANHIER F，ANSORENA E，SILVA JM，et al. PLGA- based nanoparticles：an overview of biomedical applications[J]. J Control Release，2012，161(2)：505-522.
[24] NAIR SB，DILEEP A，RAJANIKANT GK. Nanotechnology based diagnostic and therapeutic strategies for neuroscience with special emphasis on ischemic stroke[J]. Curr Med Chem，2012，19(5)：744-756.
[25] REDDY MK，WU L，KOU W，et al. Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress[J]. Appl Biochem Biotechnol，2008，151(2/3)：565-577.
, 百拇医药
[26] REDDY MK，LABHASETWAR V. Nanoparticle-mediated delivery of superoxide dismutase to the brain：an effective strategy to reduce ischemia-reperfusion injury[J]. FASEB J，2009，23(5)：1384-1395.
[27] CHEN H，SPAGNOLI F，BURRIS M，et al. Nanoerythropoietin is 10-times more effective than regular erythropoietin in neuroprotection in a neonatal rat model of hypoxia and ischemia[J]. Stroke，2012，43(3)：884-887.
[28] MDZINARISHVILI A，SUTARIYA V，TALASILA PK，et al. Engineering triiodothyronine(T3)nanoparticle for use in ischemic brain stroke[J]. Drug Deliv Transl Res，2013，3(4)：309-317.
, http://www.100md.com
[29] MOHAMMADI-SAMANI S，TAGHIPOUR B. PLGA micro and nanoparticles in delivery of peptides and proteins；problems and approaches[J]. Pharm Dev Technol，2014，20(4)：385-393.
[30] SOARES PIP，SOUSA AI，SILVA JC，et al. Chitosan- based nanoparticles as drug delivery systems for doxorubicin：optimization and modelling[J]. Carbohydr Polym，2016，147：304-312.
[31] RAMPINO A，BORGOGNA M，BLASI P，et al. Chitosan nanoparticles：preparation，size evolution and stability[J].Int J Pharm，2013，455(1/2)：219-228.
, 百拇医药
[32] AHMAD N，AHMAD R，NAQVI AA，et al. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of cerebral ischemia[J]. Int J Biol Macromol，2016，91：640-655.
[33] VERMA SK，ARORA I，JAVED K，et al. Enhancement in the neuroprotective power of riluzole against cerebral ischemia using a brain targeted drug delivery vehicle[J]. ACS Appl Mater Interfaces，2016，8(30)：19716-19723., 百拇医药(吴雅云 庞鑫 刘刚)